Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the Efficacy and Safety of Azilsartan in Adult Patients with Essential Hypertension: A Randomized, Phase-III Clinical Study in India.
Sinha S, Chary S, Reddy Bandi M, Thakur P, Talluri L, Reddy VK, Agarwal M, Naik K S, Azilsartan Study In Indian Adult Patients Of Essential Hypertension Investigators Azilehi Group. Sinha S, et al. Among authors: agarwal m. J Assoc Physicians India. 2021 Feb;69(2):35-39. J Assoc Physicians India. 2021. PMID: 33527809 Clinical Trial.
Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study.
Basu I, Agarwal M, Shah V, Shukla V, Naik S, Supe PD, Srivastava MK, Giriraja KV, Pinjar P, Mishra PK, Joshi S, Vijayakumar R, van de Witte S. Basu I, et al. Among authors: agarwal m. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-10. doi: 10.1080/21645515.2021.1885278. Epub 2021 May 6. Hum Vaccin Immunother. 2022. PMID: 33957854 Free PMC article. Clinical Trial.
Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study).
Krishnappa M, Patil K, Parmar K, Trivedi P, Mody N, Shah C, Faldu K, Maroo S; PRESS XII study group; Parmar D. Krishnappa M, et al. Cardiovasc Diabetol. 2020 Jun 19;19(1):93. doi: 10.1186/s12933-020-01073-w. Cardiovasc Diabetol. 2020. PMID: 32560724 Free PMC article. Clinical Trial.
Efficacy and safety of fixed dose combination of atorvastatin and hydroxychloroquine: a randomized, double-blind comparison with atorvastatin alone among Indian patients with dyslipidemia.
Pareek A, Chandurkar N, Thulaseedharan NK, Legha R, Agarwal M, Mathur SL, Salkar HR, Pednekar S, Pai V, Sriram U, Khyalappa R, Parmar M, Agrawal N, Dhruv U, Saxena S. Pareek A, et al. Among authors: agarwal m. Curr Med Res Opin. 2015 Nov;31(11):2105-17. doi: 10.1185/03007995.2015.1087989. Epub 2015 Oct 8. Curr Med Res Opin. 2015. PMID: 26371518 Clinical Trial.
Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Amarenco G, Sutory M, Zachoval R, Agarwal M, Del Popolo G, Tretter R, Compion G, De Ridder D. Amarenco G, et al. Among authors: agarwal m. Neurourol Urodyn. 2017 Feb;36(2):414-421. doi: 10.1002/nau.22945. Epub 2015 Dec 29. Neurourol Urodyn. 2017. PMID: 26714009 Clinical Trial.
2,252 results